← All organizations
Highest phase reached
Phase 4
First clinical trial
Apr 1, 1994Last known activity
Feb 19, 2025
Timeline
1960s
- Nov 3, 1961
United States Agency for International Development— Founded
Drugs by trial phase (81 distinct, 76 trials)
Phase 4 (23 own, 0 via acquisition)
Phase 3 (25 own, 0 via acquisition)
Phase 2 (12 own, 0 via acquisition)
Phase 1 (15 own, 0 via acquisition)
Other trials (6 own, 0 via acquisition)
Indications
Studied for
- Acquired Immunodeficiency Syndrome
- Birth Weight
- Bronchiolitis
- Communicable Diseases
- Constipation
- Diarrhea
- Elephantiasis
- Elephantiasis, Filarial
- Enterocolitis
- Enterocolitis, Necrotizing
- Filariasis
- Gonorrhea
- Helminthiasis
- Herpes Simplex
- HIV Infections
- HIV Seropositivity
- Infant Death
- Infant, Newborn, Diseases
- Infections
- Lymphedema
- Malaria
- Malaria, Falciparum
- Malnutrition
- Maternal Death
- Meningitis
- Neonatal Sepsis
- Night Blindness
- Perinatal Death
- Pneumonia
- Premature Birth
- Puerperal Infection
- Sepsis
- Sexually Transmitted Diseases
- Syphilis
- Tinea Capitis
- Toxemia
- Trichomonas Vaginitis
- Tuberculosis
- Tuberculosis, Meningeal
- Vaginitis
- Vitamin A Deficiency
Recent trials (50)
- NCT06694753CollaboratorPhase 1Feb 19, 2025
- NCT06568484CollaboratorPhase 3Nov 30, 2024
- NCT06253715CollaboratorPhase 3Nov 27, 2024
- NCT06560853CollaboratorN/AFeb 27, 2024
- NCT06087913CollaboratorPhase 1Nov 8, 2023
- NCT05458765CollaboratorPhase 2Jun 21, 2022
- NCT05343312CollaboratorPhase 4Mar 16, 2022
- NCT04767217CollaboratorPhase 4Jun 14, 2021
- NCT04778813CollaboratorPhase 4Jun 1, 2021
- NCT04767191CollaboratorPhase 4Mar 15, 2021
- NCT04814927CollaboratorPhase 4Mar 1, 2021
- NCT03762772CollaboratorPhase 1Dec 10, 2018
- NCT03341754CollaboratorPhase 1Sep 15, 2018
- NCT03885973CollaboratorPhase 2/Phase 3Jul 28, 2018
- NCT03431558CollaboratorPhase 3May 1, 2018
Details
- Founded
- Washington, DC, US Nov 3, 1961
- Last known activity
- Feb 19, 2025